Patient Controlled Injectors Market 2027 By Product, Application, Distributional Channel, and Geography | The Insight Partners

Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Electronical Injectors, Mechanical Injectors, Others); Application (Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, Others); Distributional Channel (Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies), and Geography

Report Code: TIPRE00015234 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Patient-controlled injectors are the latest innovation in the administration of injections. There are high unmet needs of patients requiring the patient-controlled injectors as it has greater ease and comfort than spring-based auto-injectors. Ergonomically developed and design patient-controlled injectors can help optimize self-care, making it easy for patients to hold the system and administer the dosages at just one press. Patient-controlled injectors enable the patient to control the dosage rate independently, which reduces the pain, unlike spring-based auto-injectors.

MARKET DYNAMICS

The greater ease and comfort for administration of injections, and rising investment in innovation, will spur the growth of the market. Additionally, controlled release of the patient-controlled injectors helps the patient to administration the injection by own and helps them to decide their own dosage rate, factors like these will boost the market growth to significant extent over the forecast period. However, lack of awareness about the patient-controlled injectors may restrain the growth of the market in the forecasted period.

MARKET SCOPE

The "Global patient controlled injectors Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of patient controlled injectors market with detailed market segmentation by product, application, and geography. The global patient controlled injectors market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading patient controlled injectors market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global patient controlled injectors market is segmented on the product type, and application. Based on product type, the global patient controlled injectors market is segmented electronical injectors, mechanical injectors and others. based on application, the global patient controlled injectors market is segmented into cancer treatment, auto-immune treatment, blood disorders treatment, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global patient controlled injectors market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The patient controlled injectors market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting patient controlled injectors market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Patient controlled injectors market in these regions.



Get more information on this report :

MARKET PLAYERS


The reports cover key developments in the patient controlled injectors market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from patient controlled injectors market are anticipated to lucrative growth opportunities in the future with the rising demand for patient controlled injectors market in the global market. Below mentioned is the list of few companies engaged in the patient controlled injectors market.

The report also includes the profiles of key patient controlled injectors market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   West Pharmaceutical Services, Inc.
  •   Unilife Corporation
  •   Sensile Medical AG
  •   Roche
  •   Johnson and Johnson Services, Inc.
  •   Westbourne Medical Limited
  •   Enable Injections
  •   scPharmaceuticals
  •   United Therapeutics Corporation
  •   BD

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Patient Controlled Injectors Market - By Product
1.3.2 Patient Controlled Injectors Market - By Application
1.3.3 Patient Controlled Injectors Market - By Distributional Channel
1.3.4 Patient Controlled Injectors Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PATIENT CONTROLLED INJECTORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PATIENT CONTROLLED INJECTORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PATIENT CONTROLLED INJECTORS MARKET - GLOBAL MARKET ANALYSIS
6.1. PATIENT CONTROLLED INJECTORS - GLOBAL MARKET OVERVIEW
6.2. PATIENT CONTROLLED INJECTORS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PATIENT CONTROLLED INJECTORS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ELECTRONICAL INJECTORS
7.3.1. Overview
7.3.2. Electronical Injectors Market Forecast and Analysis
7.4. MECHANICAL INJECTORS
7.4.1. Overview
7.4.2. Mechanical Injectors Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. PATIENT CONTROLLED INJECTORS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER TREATMENT
8.3.1. Overview
8.3.2. Cancer Treatment Market Forecast and Analysis
8.4. AUTO-IMMUNE TREATMENT
8.4.1. Overview
8.4.2. Auto-immune Treatment Market Forecast and Analysis
8.5. BLOOD DISORDERS TREATMENT
8.5.1. Overview
8.5.2. Blood Disorders Treatment Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. PATIENT CONTROLLED INJECTORS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTIONAL CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTIONAL CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. MAIL ORDER PHARMACIES
9.5.1. Overview
9.5.2. Mail Order Pharmacies Market Forecast and Analysis
10. PATIENT CONTROLLED INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Patient Controlled Injectors Market Overview
10.1.2 North America Patient Controlled Injectors Market Forecasts and Analysis
10.1.3 North America Patient Controlled Injectors Market Forecasts and Analysis - By Product
10.1.4 North America Patient Controlled Injectors Market Forecasts and Analysis - By Application
10.1.5 North America Patient Controlled Injectors Market Forecasts and Analysis - By Distributional Channel
10.1.6 North America Patient Controlled Injectors Market Forecasts and Analysis - By Countries
10.1.6.1 United States Patient Controlled Injectors Market
10.1.6.1.1 United States Patient Controlled Injectors Market by Product
10.1.6.1.2 United States Patient Controlled Injectors Market by Application
10.1.6.1.3 United States Patient Controlled Injectors Market by Distributional Channel
10.1.6.2 Canada Patient Controlled Injectors Market
10.1.6.2.1 Canada Patient Controlled Injectors Market by Product
10.1.6.2.2 Canada Patient Controlled Injectors Market by Application
10.1.6.2.3 Canada Patient Controlled Injectors Market by Distributional Channel
10.1.6.3 Mexico Patient Controlled Injectors Market
10.1.6.3.1 Mexico Patient Controlled Injectors Market by Product
10.1.6.3.2 Mexico Patient Controlled Injectors Market by Application
10.1.6.3.3 Mexico Patient Controlled Injectors Market by Distributional Channel
10.2. EUROPE
10.2.1 Europe Patient Controlled Injectors Market Overview
10.2.2 Europe Patient Controlled Injectors Market Forecasts and Analysis
10.2.3 Europe Patient Controlled Injectors Market Forecasts and Analysis - By Product
10.2.4 Europe Patient Controlled Injectors Market Forecasts and Analysis - By Application
10.2.5 Europe Patient Controlled Injectors Market Forecasts and Analysis - By Distributional Channel
10.2.6 Europe Patient Controlled Injectors Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Patient Controlled Injectors Market
10.2.6.1.1 Germany Patient Controlled Injectors Market by Product
10.2.6.1.2 Germany Patient Controlled Injectors Market by Application
10.2.6.1.3 Germany Patient Controlled Injectors Market by Distributional Channel
10.2.6.2 France Patient Controlled Injectors Market
10.2.6.2.1 France Patient Controlled Injectors Market by Product
10.2.6.2.2 France Patient Controlled Injectors Market by Application
10.2.6.2.3 France Patient Controlled Injectors Market by Distributional Channel
10.2.6.3 Italy Patient Controlled Injectors Market
10.2.6.3.1 Italy Patient Controlled Injectors Market by Product
10.2.6.3.2 Italy Patient Controlled Injectors Market by Application
10.2.6.3.3 Italy Patient Controlled Injectors Market by Distributional Channel
10.2.6.4 Spain Patient Controlled Injectors Market
10.2.6.4.1 Spain Patient Controlled Injectors Market by Product
10.2.6.4.2 Spain Patient Controlled Injectors Market by Application
10.2.6.4.3 Spain Patient Controlled Injectors Market by Distributional Channel
10.2.6.5 United Kingdom Patient Controlled Injectors Market
10.2.6.5.1 United Kingdom Patient Controlled Injectors Market by Product
10.2.6.5.2 United Kingdom Patient Controlled Injectors Market by Application
10.2.6.5.3 United Kingdom Patient Controlled Injectors Market by Distributional Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Patient Controlled Injectors Market Overview
10.3.2 Asia-Pacific Patient Controlled Injectors Market Forecasts and Analysis
10.3.3 Asia-Pacific Patient Controlled Injectors Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Patient Controlled Injectors Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Patient Controlled Injectors Market Forecasts and Analysis - By Distributional Channel
10.3.6 Asia-Pacific Patient Controlled Injectors Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Patient Controlled Injectors Market
10.3.6.1.1 Australia Patient Controlled Injectors Market by Product
10.3.6.1.2 Australia Patient Controlled Injectors Market by Application
10.3.6.1.3 Australia Patient Controlled Injectors Market by Distributional Channel
10.3.6.2 China Patient Controlled Injectors Market
10.3.6.2.1 China Patient Controlled Injectors Market by Product
10.3.6.2.2 China Patient Controlled Injectors Market by Application
10.3.6.2.3 China Patient Controlled Injectors Market by Distributional Channel
10.3.6.3 India Patient Controlled Injectors Market
10.3.6.3.1 India Patient Controlled Injectors Market by Product
10.3.6.3.2 India Patient Controlled Injectors Market by Application
10.3.6.3.3 India Patient Controlled Injectors Market by Distributional Channel
10.3.6.4 Japan Patient Controlled Injectors Market
10.3.6.4.1 Japan Patient Controlled Injectors Market by Product
10.3.6.4.2 Japan Patient Controlled Injectors Market by Application
10.3.6.4.3 Japan Patient Controlled Injectors Market by Distributional Channel
10.3.6.5 South Korea Patient Controlled Injectors Market
10.3.6.5.1 South Korea Patient Controlled Injectors Market by Product
10.3.6.5.2 South Korea Patient Controlled Injectors Market by Application
10.3.6.5.3 South Korea Patient Controlled Injectors Market by Distributional Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Patient Controlled Injectors Market Overview
10.4.2 Middle East and Africa Patient Controlled Injectors Market Forecasts and Analysis
10.4.3 Middle East and Africa Patient Controlled Injectors Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Patient Controlled Injectors Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Patient Controlled Injectors Market Forecasts and Analysis - By Distributional Channel
10.4.6 Middle East and Africa Patient Controlled Injectors Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Patient Controlled Injectors Market
10.4.6.1.1 South Africa Patient Controlled Injectors Market by Product
10.4.6.1.2 South Africa Patient Controlled Injectors Market by Application
10.4.6.1.3 South Africa Patient Controlled Injectors Market by Distributional Channel
10.4.6.2 Saudi Arabia Patient Controlled Injectors Market
10.4.6.2.1 Saudi Arabia Patient Controlled Injectors Market by Product
10.4.6.2.2 Saudi Arabia Patient Controlled Injectors Market by Application
10.4.6.2.3 Saudi Arabia Patient Controlled Injectors Market by Distributional Channel
10.4.6.3 U.A.E Patient Controlled Injectors Market
10.4.6.3.1 U.A.E Patient Controlled Injectors Market by Product
10.4.6.3.2 U.A.E Patient Controlled Injectors Market by Application
10.4.6.3.3 U.A.E Patient Controlled Injectors Market by Distributional Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Patient Controlled Injectors Market Overview
10.5.2 South and Central America Patient Controlled Injectors Market Forecasts and Analysis
10.5.3 South and Central America Patient Controlled Injectors Market Forecasts and Analysis - By Product
10.5.4 South and Central America Patient Controlled Injectors Market Forecasts and Analysis - By Application
10.5.5 South and Central America Patient Controlled Injectors Market Forecasts and Analysis - By Distributional Channel
10.5.6 South and Central America Patient Controlled Injectors Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Patient Controlled Injectors Market
10.5.6.1.1 Brazil Patient Controlled Injectors Market by Product
10.5.6.1.2 Brazil Patient Controlled Injectors Market by Application
10.5.6.1.3 Brazil Patient Controlled Injectors Market by Distributional Channel
10.5.6.2 Argentina Patient Controlled Injectors Market
10.5.6.2.1 Argentina Patient Controlled Injectors Market by Product
10.5.6.2.2 Argentina Patient Controlled Injectors Market by Application
10.5.6.2.3 Argentina Patient Controlled Injectors Market by Distributional Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PATIENT CONTROLLED INJECTORS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PATIENT CONTROLLED INJECTORS MARKET, KEY COMPANY PROFILES
13.1. WEST PHARMACEUTICAL SERVICES, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. UNILIFE CORPORATION
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. SENSILE MEDICAL AG
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ROCHE
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. JOHNSON AND JOHNSON SERVICES, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. WESTBOURNE MEDICAL LIMITED
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ENABLE INJECTIONS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SCPHARMACEUTICALS
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. UNITED THERAPEUTICS CORPORATION
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BD
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. West Pharmaceutical Services, Inc.
2. Unilife Corporation
3. Sensile Medical AG
4. Roche
5. Johnson and Johnson Services, Inc.
6. Westbourne Medical Limited
7. Enable Injections
8. scPharmaceuticals
9. United Therapeutics Corporation
10. BD
TIPRE00015234
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking